Document Detail


Ursodeoxycholic acid modulates the ubiquitin-proteasome degradation pathway of p53.
MedLine Citation:
PMID:  20807506     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
p53/Mdm-2 interaction is a prime target of ursodeoxycholic acid (UDCA) for regulating apoptosis in primary rat hepatocytes. Here, we further explored the role of UDCA in downregulating p53 by Mdm-2. UDCA reduced the stability of p53 by decreasing protein half-life. Although proteasomal activity was slightly increased with UDCA, the effect was also observed for other bile acids. More importantly, immunoprecipitation assays revealed that UDCA promoted p53 ubiquitination, therefore leading to increased p53 degradation. In this regard, proteasome inhibition after UDCA pre-treatment resulted in accumulation of ubiquitinated p53, which in turn was prevented in cells overexpressing a mutated form of p53 that does not undergo Mdm-2 ubiquitination. The involvement of Mdm-2 in UDCA-mediated response was further confirmed by siRNA-mediated gene silencing experiments. Finally, the protective effect of UDCA against p53-induced apoptosis was abolished after inhibition of proteasome activity and prevention of p53 ubiquitination by Mdm-2. These findings suggest that UDCA protects cells from p53-mediated apoptosis by promoting its degradation via the Mdm-2-ubiquitin-proteasome pathway.
Authors:
Joana D Amaral; Rui E Castro; Susana Solá; Clifford J Steer; Cecília M P Rodrigues
Related Documents :
11175336 - Formation of nuclear bax/p53 complexes is associated with chemotherapy induced apoptosis.
8353276 - Hematopoietic cells from mice deficient in wild-type p53 are more resistant to inductio...
9336156 - Platelet-derived growth factor (pdgf)-signaling mediates radiation-induced apoptosis in...
19850936 - The alpha-secretase-derived n-terminal product of cellular prion, n1, displays neuropro...
20182586 - Quantification and mechanisms of oleic acid-induced steatosis in hepg2 cells.
22546996 - Lessons of leprosy: the emergence of th17 cytokines during type ii reactions (enl) is t...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-08-31
Journal Detail:
Title:  Biochemical and biophysical research communications     Volume:  400     ISSN:  1090-2104     ISO Abbreviation:  Biochem. Biophys. Res. Commun.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-04     Completed Date:  2010-11-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372516     Medline TA:  Biochem Biophys Res Commun     Country:  United States    
Other Details:
Languages:  eng     Pagination:  649-54     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Affiliation:
Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Lisbon 1649-003, Portugal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apoptosis / drug effects*
Cells, Cultured
Cytoprotection*
Half-Life
Hepatocytes / drug effects*,  metabolism
Proteasome Endopeptidase Complex / metabolism*
Proto-Oncogene Proteins c-mdm2 / metabolism
Rats
Tumor Suppressor Protein p53 / metabolism*
Ubiquitin / metabolism*
Ubiquitination / drug effects
Ursodeoxycholic Acid / pharmacology*
Chemical
Reg. No./Substance:
0/Tumor Suppressor Protein p53; 0/Ubiquitin; 128-13-2/Ursodeoxycholic Acid; EC 3.4.25.1/Proteasome Endopeptidase Complex; EC 6.3.2.19/Mdm2 protein, rat; EC 6.3.2.19/Proto-Oncogene Proteins c-mdm2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Zinc finger-zinc finger interaction between the transcription factors, GATA-1 and Sp1.
Next Document:  Transmission of circulating cell-free AA amyloid oligomers in exosomes vectors via a prion-like mech...